NASDAQ
No price data available for this timeframe.
Fulcrum Therapeutics, Inc. (FULC) has a current ratio of 27.40x as of Tuesday, May 26, 2026. This represents a 69.85% increase compared to its 12-month average of 16.13x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.